Karyopharm Therapeutics Inc (KPTI) earnings · rev $146.1M
These earnings events as JSON? API free 100/dayKaryopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
This KPTI earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported KPTI revenue for 2025-12-31 was $146.1M. Net income was -$196.0M. Revenue was up 0.6% from 2024-12-31 to 2025-12-31. KPTI currently screens at market cap $205.6M.
When the next KPTI 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 0.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full KPTI research stays on the stock page; the tape stays on the quote page.
KPTI earnings FAQ
What are KPTI's latest revenue and net income?
Latest cached Karyopharm Therapeutics Inc (KPTI) revenue for Dec 31, 2025 was $146.1M. Net income was -$196.0M. Statements: https://lician.com/financials/kpti
What is KPTI's latest diluted EPS?
Latest cached Karyopharm Therapeutics Inc (KPTI) diluted EPS for Dec 31, 2025 was -$17.93.
What period does the latest KPTI earnings print cover?
The latest cached Karyopharm Therapeutics Inc (KPTI) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did KPTI revenue change from the prior cached period?
Cached Karyopharm Therapeutics Inc (KPTI) revenue was up 0.6% from $145.2M (Dec 31, 2024) to $146.1M (Dec 31, 2025). Statements: https://lician.com/financials/kpti
Where are KPTI earnings listed?
Cached earnings facts for Karyopharm Therapeutics Inc (KPTI) are listed at https://lician.com/earnings/kpti. Statements: https://lician.com/financials/kpti
Not investment advice.